Ottobock reports November 12, 2026 and Ottobock stock costs EUR 54.30

Published on 10/14/2026 at 14:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Core revenue rose 11.70 percent in fiscal year 2025. Ottobock stock costs EUR 54.30 on October 14, 2026.

Reporting date and valuation

Ottobock's next quarterly publication is scheduled for November 12, 2026.
Core revenue increased 11.70 percent in fiscal year 2025.
Ottobock stock costs EUR 54.30 at Lang & Schwarz on October 14, 2026 at 2:37 p.m. CEST.
The market capitalization was EUR 3.5 billion as of September 24, 2026.

Ottobock, DE000BCK2223, Illustration mit AI erstellt.

Ottobock (ISIN DE000BCK2223) has scheduled its next quarterly publication for November 12, 2026, while Ottobock stock was trading at EUR 54.30 at Lang & Schwarz on October 14, 2026 at 2:37 p.m. CEST. The company remains a listed medical technology business focused on prosthetics, neuro-orthotics and exoskeletons.

November report date confirmed

The November 12 reporting date appears in Ottobock's investor calendar and in the EQS News announcement dated September 22, 2026. The publication covers the company's quarterly statement for the third quarter and is the next scheduled results event listed for investors.

Core revenue grew 11.70 percent

Ottobock's investor-relations page reports core revenue of EUR 120.00 million in fiscal year 2025, up 11.70 percent from the prior year. The same page lists adjusted EBITDA of EUR 31.72 million, an increase of 29.50 percent, and adjusted group profit of EUR 13.50 million, up 83.20 percent.

These figures describe fiscal year 2025 rather than the coming third-quarter publication. For the next report, the key question is whether the revenue trend and adjusted profitability remain aligned with the annual figures. The company's investor-relations page also identifies activity in 45 countries, more than 430 patient care centers and almost 9,300 full-time employees.

Price and company valuation

The EUR 54.30 Lang & Schwarz price was accompanied by a EUR 54.20 bid and a EUR 54.40 ask at 2:37 p.m. CEST on October 14, 2026. The market capitalization was EUR 3.5 billion as of September 24, 2026, while the stock's primary listing is Xetra under ticker OBCK and WKN BCK222.

Ottobock is classified in medical products and medical technology and is included in the TecDAX. The scheduled November report therefore provides the next dated test of the operating figures, with fiscal year 2025 revenue and adjusted EBITDA as the latest disclosed benchmarks.

Trading status on October 14

Ottobock stock was trading at EUR 54.30 at Lang & Schwarz on October 14, 2026 at 2:37 p.m. CEST. The price statement uses the intraday Lang & Schwarz quotation and does not assign a separate daily percentage change.

Market context: Market report DAX.